Silvia Cruz-Gil Selected Research

Coenzyme A Ligases (Acid-Thiol Ligases)

1/2019	A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment.
1/2018	Targeting the lipid metabolic axis ACSL/SCD in colorectal cancer progression by therapeutic miRNAs: miR-19b-1 role.
11/2017	Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells.
11/2015	A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Cruz-Gil Research Topics

Disease

4	Colonic Neoplasms (Colon Cancer) 01/2019 - 11/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 11/2017
2	Neoplasms (Cancer) 10/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

4	Stearoyl-CoA DesaturaseIBA 01/2019 - 11/2015
4	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2019 - 11/2015
1	Small Untranslated RNAIBA 10/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2020
1	Adenosine Triphosphate (ATP)IBA 10/2020
1	Pharmaceutical PreparationsIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	LuciferasesIBA 01/2018
1	LipidsIBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Protein Isoforms (Isoforms)IBA 11/2017

Therapy/Procedure

1	Precision Medicine 01/2019
1	Therapeutics 11/2015